L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor
B. V. Jardim-Perassi, P. Irrera, D. Abrahams…·A. Ibrahim-Hashim
This study shows that L-DOS47, a urease immunoconjugate, enhances anti-PD1 immunotherapy efficacy in pancreatic cancer by neutralizing tumor acidity.